MedPath

ELITE LABORATORIES, INC.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

A Study to Evaluate Safety and Efficacy Following Dosing of Oxycodone/Naltrexone for Treatment of Adults With Pain Following Bunionectomy Surgery

Phase 3
Completed
Conditions
Pain
Interventions
First Posted Date
2015-03-30
Last Posted Date
2016-08-09
Lead Sponsor
Elite Laboratories, Inc
Target Recruit Count
163
Registration Number
NCT02401750
Locations
🇺🇸

Premier Research, Austin, Texas, United States

🇺🇸

Chesapeake Research Group, Pasadena, Maryland, United States

🇺🇸

Jean Brown Research, Salt Lake City, Utah, United States

and more 1 locations

A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects

Phase 3
Completed
Conditions
Withdrawal Symptoms
Interventions
Drug: Oxycodone/Naltrexone Capsules
Drug: Placebo
First Posted Date
2015-03-18
Last Posted Date
2016-08-10
Lead Sponsor
Elite Laboratories, Inc
Target Recruit Count
26
Registration Number
NCT02391571
Locations
🇺🇸

Vince and Associates, Overland Park, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath